Psychopathology, Disordered Eating, and Impulsivity as Predictors of Outcomes of Bariatric Surgery
SIDE-BAR
1 other identifier
observational
300
0 countries
N/A
Brief Summary
This study will evaluate the relationship between psychopathology, disordered eating, and impulsivity (measured by clinical interview, self-report measures, and objective testing) on changes in weight and psychosocial status in the first two years after bariatric surgery. Participants will be 300 adults who plan to undergo bariatric surgery. Participants will complete four assessments over a two-year period, one at baseline (before surgery) and 6, 12, and 24 months after surgery. Each assessment will include computer tasks, surveys, clinical interview, urine test, waist circumference and height/weight measurement. The investigators will track how psychopathology, disordered eating, and impulsivity are related to changes in weight and psychosocial status following bariatric surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2016
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 3, 2016
CompletedFirst Submitted
Initial submission to the registry
May 10, 2016
CompletedFirst Posted
Study publicly available on registry
May 17, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedResults Posted
Study results publicly available
May 16, 2024
CompletedMay 16, 2024
May 1, 2024
5.8 years
May 10, 2016
October 31, 2022
May 7, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Percent Weight Change
percent weight change from baseline
6, 12, 24 months
Eligibility Criteria
Participants will be recruited from the Bariatric Surgery Programs at the Hospital of the University of Pennsylvania and Presbyterian Medical Center, all part of Penn Medicine. The investigators will enroll participants until a total of 300 adults have completed baseline visits. Based on the investigator's previous studies of bariatric surgery patients, the investigators expect that approximately 80% of participants will be women and 20% of participants will be ethnic minorities.
You may qualify if:
- Adults aged 18-65 years old 18 years of age or above
- BMI of 35-60 kg/m2 (35 kg/m2 in the presence of significant weight-related comorbidities, including established coronary artery disease, established peripheral arterial disease, symptomatic carotid artery disease, sleep apnea, metabolic syndrome, cardiomyopathy, hypertension, and debilitating joint pain).
You may not qualify if:
- Uncontrolled hypertension (systolic blood pressure 160 or diastolic blood pressure 100mmHg)
- HbA1c 11%
- Recent history of cardiovascular disease (myocardial infarction or stroke within the past 6 months)
- Clinically significant hepatic or renal disease Long-term treatment with oral steroids
- Current use of weight loss medication (OTC or prescription)
- Psychiatric hospitalization in the past 6 months
- Psychiatric diagnosis that would contraindicate surgery (e.g., schizophrenia)
- History of bariatric surgery
- Non-ambulatory individuals, defined as those who are unable to walk without a cane or walker
- Lack of capacity to provide informed consent
- Plans to relocate from the area within 2 years
- Principal Investigator discretion
- For the cognitive, computer-based testing:
- Any impairment (physical and/or neurological) including visual or other impairment preventing cognitive task performance
- Hearing impairment, significant hearing loss (more than 20% in either ear), cochlear implants, or bi-lateral hearing aids (will be assessed on a case-by-case basis to determine whether participants are eligible to complete the Stop Signal Task)
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pennsylvanialead
- Temple Universitycollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- David Sarwer
- Organization
- Temple University
Study Officials
- PRINCIPAL INVESTIGATOR
Kelly C Allison, PhD
University of Pennsylvania
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 10, 2016
First Posted
May 17, 2016
Study Start
March 3, 2016
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
May 16, 2024
Results First Posted
May 16, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share